Perianal Abscess
18
3
3
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 18 trials
100.0%
+13.5% vs benchmark
6%
1 trials in Phase 3/4
22%
2 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (18)
The Impact of Perianal Disease on Patient's Sex Life
Perianal Abscess Recurrence and Fistula Formation: Antibiotics Following Incision and Drainage Trial
Effect of Different Sitz Bath Methods on Perianal Abscess After Surgery
Effect of Red and Blue Light Irradiation on Postoperative Wound Healing in Perianal Absces
Machine Learning-Based Risk Stratification for Fistula Formation After Perianal Abscess Drainage
Association of Intestinal Microbiota and the Onset of Perianal Abscess Based on 16S RDNA Amplicon Sequencing
Semiflex Assisted Vacuum Therapy for Perianal Abscesses/Sinuses and Fistula: a Pilot Study
Multicenter Study for Diagnosis and Treatment of Perianal Abscesses
Antibiotic Treatment foLlowing Surgical drAinage of Perianal abScess; the ATLAS Trial
Pudendal Nerve Block With Bupivacaine Alone and Bupivacaine With Methylene Blue for Postoperative Analgesia
The Immunological Differences Between Fournier Gangrene and Perianal Abscess
Abces After Incision: Recurrence or Not?
A Perianal Abscess Cavity Packing vs no Packing.
Packing of Perianal Abscess Cavities
Adjunctive Nitrous Oxide During Emergency Department Propofol Sedation in Adults
Perianal Abscess Packing Randomized ControlledTrial Pilot Study
Prevalence of Inflammatory Bowel Disease in Patients With Perianal Disease
Packing of Perianal Abscess Cavities Trial: A Randomised Multicentre Trial Comparing Packing With Non-packing of the Abscess Cavity